Vivos Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	3.09	6.26	1.64	3.52	24.03	18.21
Cash & Short-Term Investments	3.09	6.26	1.64	3.52	24.03	18.21
Cash Growth	-51.09%	281.01%	-53.31%	-85.36%	31.99%	3778.96%
Accounts Receivable	2.13	0.43	0.2	0.46	1.2	1.43
Other Receivables	-	-	-	-	-	0.08
Total Trade Receivables	2.13	0.43	0.2	0.46	1.2	1.52
Other Current Assets	0.57	0.78	0.62	1.45	2.09	0.67
Total Current Assets	5.79	7.47	2.46	5.42	27.32	20.39
Net Property, Plant & Equipment	9.03	4.41	4.7	4.78	2.83	0.87
Other Intangible Assets	2.17	0.37	0.42	0.31	0.34	0.27
Goodwill	8.46	2.84	2.84	2.84	2.84	2.67
Other Long-Term Assets	0.21	0.22	0.31	0.37	0.36	1.12
Total Assets	25.64	15.28	10.73	13.72	33.69	25.33
Accounts Payable	2.1	1.1	2.15	1.41	0.92	0.78
Accrued Expenses	2.66	2.23	2.33	1.91	2.85	1.74
Current Portion of Long-Term Debt	-	-	-	-	1.27	0.87
Current Portion of Leases	1.07	0.98	0.47	0.42	-	-
Unearned Revenue	0.24	0.4	2.14	2.93	2.4	2.94
Other Current Liabilities	0.99	0.27	0.2	0.15	0.07	1.52
Total Current Liabilities	7.44	4.98	7.29	6.81	7.51	7.84
Long-Term Debt	8.38	-	-	-	-	0.42
Long-Term Leases	3.29	1.04	1.52	1.99	-	-
Other Long-Term Liabilities	4.31	1.32	1.51	0.11	0.64	0.15
Total Long-Term Liabilities	15.98	2.35	3.03	2.11	0.64	0.57
Total Liabilities	23.11	7.33	10.32	8.92	8.15	8.41
Common Stock	0	0	-	-	0	0
Additional Paid-in Capital	121	112.14	93.46	84.27	81.16	52.25
Retained Earnings	-118.46	-104.19	-93.05	-79.47	-55.62	-35.34
Total Common Shareholders' Equity	2.53	7.96	0.41	4.8	25.54	16.92
Shareholders' Equity	2.53	7.96	0.41	4.8	25.54	16.92
Total Liabilities & Equity	25.64	15.28	10.73	13.72	33.69	25.33
Total Debt	12.74	2.01	2	2.41	1.27	1.29
Net Cash (Debt)	-9.66	4.25	-0.35	1.11	22.77	16.92
Net Cash Growth	-	-	-	-95.14%	34.58%	-
Net Cash Per Share	-0.00	0.00	-	0.00	0.03	32.86
Book Value	2.53	7.96	0.41	4.8	25.54	16.92
Book Value Per Share	0.00	0.00	0.00	0.01	0.03	32.86
Tangible Book Value	-8.1	4.74	-2.85	1.65	22.36	13.98
Tangible Book Value Per Share	-0.00	0.00	-0.00	0.00	0.03	27.15

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q